Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,375.00p
   
  • Change Today:
    -50.00p
  • 52 Week High: 4,400.00p
  • 52 Week Low: 2,325.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 3,042
  • Market Cap: £124.09m
  • Beta: 0.01

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £7,055,840
Ian James Nicholson 13,000 £308,750
Bruce Hiscock 1,236 £29,355

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £123,966,830
Castlefield Fund Partners Limited 985,000 £23,393,750
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £21,018,750
Gresham House Asset Management Limited 627,782 £14,909,822
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £14,713,125
Miton Group plc 508,135 £12,068,206
The Diverse Income Trust plc 302,300 £7,179,625
Schroders plc 284,795 £6,763,881
Wasatch Advisors, Inc. 265,000 £6,293,750
Canaccord Genuity Group Inc 259,940 £6,173,575
Adrian Williams 253,372 £6,017,585

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,375.00p
Change Today -50.00p
% Change -2.06 %
52 Week High 4,400.00p
52 Week Low 2,325.00p
Volume 3,042
Shares Issued 5.22m
Market Cap £124.09m
Beta 0.01

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.34% above the market average23.34% above the market average23.34% above the market average23.34% above the market average23.34% above the market average
90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average
Price Trend
70.59% below the market average70.59% below the market average70.59% below the market average70.59% below the market average70.59% below the market average
42.22% below the sector average42.22% below the sector average42.22% below the sector average42.22% below the sector average42.22% below the sector average
Income
61.79% above the market average61.79% above the market average61.79% above the market average61.79% above the market average61.79% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
6.38% below the market average6.38% below the market average6.38% below the market average6.38% below the market average6.38% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 11-Aug-2025

Time Volume / Share Price
13:02 421 @ 2,369.00p
12:41 2 @ 2,390.00p
12:41 4 @ 2,390.00p
11:47 20 @ 2,400.00p
11:47 0 @ 2,400.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page